secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0000950170-24-006510
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences effects 1-for-30 reverse stock split, ~210K shares outstanding
--------------------------------------------------------------------------------

- Stockholders approved reverse split at Jan 17 special meeting; board set ratio at 1-for-30.
- Reverse split effective 12:01 a.m. ET on Jan 25, 2024; common stock continues trading under REVB.
- Post-split shares outstanding ~209,911; no fractional shares, rounding up to whole shares.
- Outstanding equity awards and warrants proportionally adjusted for the 1-for-30 ratio.
- New CUSIP for common stock: 76135L507.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024006510/0000950170-24-006510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024006510/revb-20240122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-006510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer